Cafepharma Today

December 11 2024 - With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Walgreens shares surge on reported talks to be taken private
How Trump’s second term will affect the medtech industry
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Shionogi to Buy Sciele Pharma to Get U.S. Sales Staff
Bloomberg
Monday, September 1, 2008 - 11:29am
tags:
Is a Hurricane Lurking for Merck and Schering-Plough?
Seeking Alpha
Sunday, August 31, 2008 - 10:53am
tags:
Ranbaxy emerges as top pharma company (in India) in July
Smart Money, India
Sunday, August 31, 2008 - 10:30am
tags:
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
CNN Money
Sunday, August 31, 2008 - 10:26am
tags:
Bayer's Xarelto Test Program Moves Ahead Faster Than Planned
Smart Money
Sunday, August 31, 2008 - 10:24am
tags:
The Contrarian Case For Pfizer
Investopedia
Saturday, August 30, 2008 - 10:35am
tags:
Cholesterol drugs' cancer risk in spotlight
Yahoo
Saturday, August 30, 2008 - 10:34am
tags:
Generics Face Uphill Battle
Forbes
Saturday, August 30, 2008 - 10:33am
tags:
Stent Makers Getting Desperate
Motley Fool
Saturday, August 30, 2008 - 10:33am
tags:
Court sides with Pfizer over Lipitor ingredient patents
Bizjournals
Saturday, August 30, 2008 - 10:32am
tags:
BDSI shares jump for 2nd straight day after Onsolis news
Bizjournals
Saturday, August 30, 2008 - 10:28am
tags:
Cambrex Corporation Q2 2008 Earnings Call Transcript
Seeking Alpha
Saturday, August 30, 2008 - 10:26am
tags:
Health Winners & Losers: Pfizer
Yahoo/The Street
Saturday, August 30, 2008 - 10:25am
tags:
Technical Outlook: Bullish on Biotech
Yahoo/The Street
Saturday, August 30, 2008 - 10:25am
tags:
BioSyent Releases Financial Results-Second Quarter 2008
Genetic Engineering News
Saturday, August 30, 2008 - 10:22am
tags:
Affymax, Takeda Nix Hematide After FDA and CMS Decisions
BioWorld Online
Saturday, August 30, 2008 - 10:16am
tags:
GlaxoSmithKline signs collaboration agreement with Valeant Pharmaceuticals
Pharmaceutical Business Review
Saturday, August 30, 2008 - 10:15am
tags:
Biotech firms plant roots in Tucson area to lure top talent
AZ Central
Saturday, August 30, 2008 - 10:12am
tags:
KV expects October due date for preterm labor drug approval
St. Louis Business Journal, MO
Saturday, August 30, 2008 - 10:05am
tags:
Takeda And Affymax Provide Clinical Development Update For Hematide In Chemotherapy-Induced Anemia
Medical News Today
Saturday, August 30, 2008 - 10:00am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)
Drug Channels
Infant RSV Vaccination Trouble
In the Pipeline
The BioSecure Act Falters?
In the Pipeline
Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)
Drug Channels
Computational Care
In the Pipeline
The Rings Less Traveled
In the Pipeline
Now That's What I Call Disordered
In the Pipeline
Do They Even Bind?
In the Pipeline

Latest Jobs

Virtual Biopharma Sales Specialist
Raleigh, North Carolina, 27601
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Portfolio Sales Specialist - North Dakota / South Dakota / Nebraska
Lincoln, Nebraska, 68511
ICU Medical
Bilingual Business Development Representative
Kennedy Space Center, Florida
Complete Care
Business Development Manager, Facial - Chevy Chase, MD
Chevy Chase, Maryland, 20815
AbbVie
Virtual Biopharma Sales Specialist
Dallas, Texas, 75215
Syneos Health/ inVentiv Health Commercial LLC
Regional Director, Central Baltimore, Maryland, United States
Baltimore, Maryland, 21276
TBWA\Chiat\Day
Account Executive
San Antonio, Texas, 78208
Elara Caring
Nobel Biocare Regional Manager - Mid Atlantic
Washington, District of Columbia, 20022
enVista
Senior Manager, Professional Affairs (Northeast)
Jersey City, New Jersey, 07390
Bausch + Lomb
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information